In order to determine whether the tissue-specific alterations observed in the animal models correspond to elevated serum concentrations of MAP2 and NF-L in human stroke patients, blood samples of 81 patients (Table 2) were analyzed at day 1 and day 3 after ischemia onset as indicated by the awareness of neurological symptoms. The gene discussed is MAP2; the disease is ischemia.